Nutrasource Diagnostics Inc.
Guelph, Ontario, N1G 0B4, Canada
NCT Number: NCT01690312
The objective of this study is to determine the acute and chronic [4-week] effects of a high-DHA fish oil supplement on fasting and post-prandial (post-meal) biomarkers of cardiovascular disease risk, in adults on Statin therapy.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Guelph, Ontario, N1G 0B4, Canada
This study involves fasted and post-prandial components.
Fasted Study:
Participants will provide fasting blood samples pre-and post-intervention [4-week administration of supplement or placebo] in Treatment Period I. Participants will again provide fasting blood samples pre-and post-intervention [4-week administration of supplement or placebo, opposite to Treatment Period I] during Treatment Period II.
There will be a 4-week washout period during the two Treatment Periods.
Post-prandial study:
Participants will also complete a post-prandial study pre-and post-intervention during each Treatment Period.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
On Day 1 and Day 15, participants will receive a 2-week supply of study supplements and will be instructed to consume 4 capsules per day. Each capsule contains 1000 mg of fish oil [620 mg of DHA and 150 mg of EPA], providing a total daily dosage of 4000 mg of fish oil [3080 mg of DHA+EPA].
On Day 1 and Day 15, participants will receive a 2-week supply of study supplements and will be instructed to consume 4 capsules per day. Each capsule contains 1000 mg of olive oil, providing a total daily dosage of 4000 mg of olive oil.
Time frame: 0 and 4 weeks
Fasted and postprandial samples will be drawn (hourly up to 6 hours).
Time frame: 0 and 4 weeks
Fasted and postprandial samples will be drawn (every 30 minutes up to 2 hours).
Time frame: 0 and 4 weeks
Fasted and postprandial samples will be drawn (every 30 minutes up to 2 hours).
Time frame: 0 and 4 weeks
A fasted blood sample will be taken.
Time frame: 0 and 4 weeks
A fasted blood sample will be taken.
Time frame: 0 and 4 weeks
A fasted blood sample will be taken.
Time frame: 0 and 4 weeks
A fasted blood sample will be taken.
Time frame: 0 and 4 weeks
A fasted blood sample will be taken.
Time frame: 0 and 4 weeks
A fasted blood sample will be taken.
Time frame: 0 and 4 weeks
A fasted blood sample will be taken.
Time frame: 0 and 4 weeks
A fasted blood sample will be taken.
Time frame: 0 and 4 weeks
A fasted blood sample will be taken.
Time frame: 0 and 4 weeks
A fasted blood sample will be taken.
Time frame: 0 and 4 weeks
A fasted blood sample will be taken.
Time frame: 0 and 4 weeks
A fasted blood sample will be taken.
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.
Network
Clinical Study to Assess the Acute and Chronic Effects of a High-DHA Fish Oil on Fasting and Post-Prandial Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00374595
Avitaminosis, Cardiovascular Disease
Omaha, Nebraska, United States
View Trial DetailsNCT02821104
Cardiovascular Disease, Cardiovascular Diseases
Columbus, Ohio, United States
View Trial DetailsNCT00508937
Cardiovascular Disease, Cardiovascular Diseases
Berkeley, California, United States
View Trial DetailsNCT01427855
Cardiovascular Disease, Cardiovascular Diseases
Berkeley, California, United States
View Trial Details